Background
Heparin binding epidermal growth factor like growth factor (HB-EGF) is a member of the epidermal growth factor family. The role of HB-EGF in cardiovascular disease such as atherosclerosis has been well-reported but its pertinence to cerebrovascular disease including hydrocephalus is unknown. In our laboratory human HB-EGF transgenic mice have been observed to demonstrate communicating hydrocephalus. The goal of this study was to find any difference in expression of three genes in vascular-lining cells under varying concentration of this growth factor.
Materials and methods
Two cell groups of murine microvascular endothelial and non-endothelial cell were exposed to 10, 100, and 1000 ng/ml of recombinant human HB-EGF (rhHB-EGF). Cellular response to rhHB-EGF was examined by quantitative real time reverse transcription polymerase chain reaction focusing on mRNA expression of vascular endothelial growth factor (VEGF), transforming growth factor β1 (TGF-β1), and tumor necrosis factor α (TNF-α), that may be associated with hydrocephalus. Also, VEGF protein levels in the culture supernatants of these cells to rhHB-EGF were measured by enzyme linked immunosorbent assay.
Results
The results indicated that VEGF mRNA was significantly increased by 3-5 fold in endothelial cells treated with rhHB-EGF relative to the untreated control (p < 0.05). As compared to the control, mRNA expression of TNF-α in endothelial cells was significantly increased by 3, 9, and 13 fold at 12 h following 10, 100, and 1000 ng/ml of rhHB-EGF treatment, respectively (p < 0.05). Also, TGF-β1 mRNA in non-endothelial cells was significantly elevated by 4, 6, and 7 fold at 24 h following introduction of 10, 100, and 1000 ng/ml of rhHB-EGF, respectively (p < 0.05). When exposed to rhHB-EGF, VEGF protein levels in the conditioned media of endothelial cells were detectable but those in non-endothelial groups were undetectable over 1-6 h period.
Conclusion
These data demonstrated that rhHB-EGF led to induction of VEGF and TNF-α in microvascular endothelial cells and upregulation of TGF-β1 in non-endothelial cells from murine origin. Our findings support a hypothesis that human HB-EGF could activate multiple mouse genes reportedly linked to hydrocephalus and that it is worthwhile to assay these factors in cerebrospinal fluid of animal models for hydrocephalus. 
